Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-2580, USA.
Int J Obes (Lond). 2010 Feb;34(2):401-5. doi: 10.1038/ijo.2009.240. Epub 2009 Nov 24.
The age-induced decline in the body's ability to fight disease is exacerbated by obesity and metabolic disease. Using a mouse model of diet-induced obesity, the combined challenge of a high-fat diet and age on liver morphology and biochemistry was characterized, while evaluating the potential of 15 min per day of high frequency (90 Hz), extremely low-magnitude (0.2 G) mechanical signals (LMMS) to suppress lipid accumulation in the liver. Following a 36-week protocol (animals 43 weeks of age), suppression of hepatomegaly and steatosis was reflected by a 29% lower liver mass in LMMS animals as compared with controls. Average triglyceride content was 101.7+/-19.4 microg mg(-1) tissue in the livers of high-fat diet control (HFD) animals, whereas HFD+LMMS animals realized a 27% reduction to 73.8+/-22.8 microg mg(-1) tissue. In HFD+LMMS animals, liver free fatty acids were also reduced to 0.026+/-0.009 microEq mg(-1) tissue from 0.035+/-0.005 microEq mg(-1) tissue in HFD. Moderate to severe micro- and macrovesicular steatosis in HFD was contrasted to a 49% reduction in area covered by the vacuoles of at least 15 microm(2) in size in HFD+LMMS animals. These data provide preliminary evidence of the ability of LMMS to attenuate the progression of fatty liver disease, most likely achieved indirectly by suppressing adipogenesis and thus the total adipose burden through life, thereby reducing a downstream challenge to liver morphology and function.
随着年龄的增长,机体对抗疾病的能力下降,肥胖和代谢性疾病则加剧了这一趋势。本研究利用饮食诱导肥胖的小鼠模型,研究了高脂肪饮食和年龄对肝脏形态和生化的综合影响,并评估了每天 15 分钟高频(90Hz)、极低幅度(0.2G)机械信号(LMMS)抑制肝脏脂质积累的潜力。在 36 周的方案(动物 43 周龄)后,与对照组相比,LMMS 动物的肝脏质量减少了 29%,提示其肝肿大和脂肪变性得到了抑制。高脂肪饮食对照组(HFD)动物肝脏中的平均甘油三酯含量为 101.7+/-19.4μg/mg 组织,而 HFD+LMMS 动物的含量降低了 27%,降至 73.8+/-22.8μg/mg 组织。在 HFD+LMMS 动物中,游离脂肪酸也从 HFD 组的 0.035+/-0.005μEq/mg 组织降低至 0.026+/-0.009μEq/mg 组织。HFD 引起的中重度微泡和大泡脂肪变性与 HFD+LMMS 动物中至少 15μm2大小的空泡面积减少 49%形成对比。这些数据初步证明了 LMMS 抑制脂肪肝进展的能力,这可能是通过抑制脂肪生成,从而降低终生总脂肪负担,间接地减轻对肝脏形态和功能的下游挑战而实现的。